Herpes zoster infection in pregnancy: features and consequences

Arch Dermatol Res. 2024 Mar 15;316(4):107. doi: 10.1007/s00403-024-02842-3.

Abstract

Herpes (varicella) zoster (HZ) infection occurs in 4 people per 1000 in the general US population (irrespective of prior varicella infection and vaccination status) each year and has been the subject of scientific inquiry for decades. The consequences of infection are myriad and may depend on the dermatome of involvement as well as host factors such as age, comorbidities, prior treatment or immunization, and immunologic status. Pregnancy is associated with an altered immune and hormonal status in the mother. While maternal HZ infection during pregnancy is not uncommon, the implications for both mother and child are not well established, although multiple studies of perinatal maternal HZ infection suggest no intrauterine transmission to the fetus. We review the current literature on herpes zoster infection in pregnancy, including epidemiology, diagnosis, potential immunologic sequelae, and strategies for prevention and treatment.

Keywords: Herpes zoster; Herpes zoster vaccine; Medical dermatology; Pregnancy; Reactivation; Varicella virus.

Publication types

  • Review

MeSH terms

  • Chickenpox* / epidemiology
  • Chickenpox* / prevention & control
  • Child
  • Female
  • Herpes Zoster* / diagnosis
  • Herpes Zoster* / epidemiology
  • Herpesvirus 3, Human
  • Humans
  • Mothers
  • Pregnancy
  • Vaccination